IOSP — Innospec Balance Sheet
0.000.00%
- $1.84bn
- $1.58bn
- $1.85bn
- 90
- 60
- 22
- 59
Annual balance sheet for Innospec, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 105 | 142 | 147 | 204 | 289 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 221 | 285 | 335 | 360 | 342 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 566 | 728 | 873 | 886 | 957 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 251 | 250 | 266 | 313 | 315 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,397 | 1,571 | 1,604 | 1,707 | 1,735 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 252 | 337 | 406 | 372 | 371 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 453 | 539 | 566 | 560 | 524 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 944 | 1,032 | 1,038 | 1,147 | 1,211 |
| Total Liabilities & Shareholders' Equity | 1,397 | 1,571 | 1,604 | 1,707 | 1,735 |
| Total Common Shares Outstanding |